Conversation: Payers may forgo PA restrictions in more collaborative model
Medicare & Reimbursement Advisor Weekly, October 30, 2009
Even if the products you support are orals for cardiovascular conditions, the following may be helpful to give you insight into a plan’s new-age thinking about utilization management.
A flurry of single-source biologics with attractive side effect profiles is expected to enter the cancer care market without competition in the next few years. Requiring prior authorizations on the coming wave of expensive oncology-specific biologics is an option “but not Aetna’s preferred option as it might preclude payers from engaging in relationships with community oncologists, academic centers, hospitals, and cancer centers,” says Aetna’s Ira Klein, MD, medical director of oncology condition analysis. In lieu of a PA, Klein says payers could try a single-specialty arrangement with an oncology provider, or build a private label insurance product in which the plan acts as a third-party administrator. PAs would close the door to these arrangements and stall recent collaboration among oncology groups and payers.
Editor’s note: The complete interview will appear shortly in Oncology Business Review. I’ll forward a link.
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- Complications from immobility by body system
- Prevent dehydration with nursing interventions
- Note similarities and differences between HCPCS, CPT® codes
- The consequences of an incomplete medical record
- Q&A: Primary, principal, and secondary diagnoses
- Know guidelines and subtle differences in code descriptions for laceration repairs
- Skills of effective case managers
- OSHA fines hospitals for PPE failures related to COVID-19
- E-mailed
-
- Q&A: Primary, principal, and secondary diagnoses
- Plan ahead when creating a central billing office
- Performing a SWOT analysis
- OSHA fines hospitals for PPE failures related to COVID-19
- Note from the instructor: CMS clarifies billing guidelines on proper billing for drugs in a single-dose or single-use vial, including billing for discarded drugs
- Nine ways to meet USP 797, get ready for your next survey
- Improve documentation with 15 tips for timely record completion
- Can we charge for insertion of a PICC line when a certified nurse performs it?
- Searched
